Pediatric Multiple Sclerosis and other Demyelinating Diseases

Overview

Acronym
PeMSDD
Website
PeMSDD
Investigators
Dr. Charlie Casper
University of Utah School of Medicine
Dr. Teri L. Schreiner
University of Colorado
Dr. Manikum Moodley
Mellen Center for Multiple Scerlosis,Cleveland Clinic
Dr. Mary Rensel
Mellen Center for Multiple Scerlosis,Cleveland Clinic
Dr. Soe Mar
Washington University Pediatric MS and other Demyelinating Disease Center
Dr. Timothy Lotze
The Blue Bird Circle Clinic for Multiple Sclerosis, Texas Children’s Hospital
Dr. Anita Belman
Pediatric Multiple Sclerosis Center at New York University Langone Medical Center
Dr. Lauren Krupp
Pediatric Multiple Sclerosis Center at New York University Langone Medical Center
Dr. Jan-Mendelt Tillema
Mayo Clinic Pediatric MS Center
Dr. Moses Rodriguez
Mayo Clinic Pediatric MS Center
Dr. Leslie Benson
Pediatric Multiple Sclerosis and Related Disorders Program at Boston Children’s Hospital
Dr. Mark Gorman
Pediatric Multiple Sclerosis and Related Disorders Program at Boston Children’s Hospital
Dr. Tanuja Chitnis
Partners Pediatric MS Center at the Massachusetts General Hospital for Children
Dr. Jennifer Graves
UCSF Regional Pediatric MS Center
Dr. Emmanuelle Waubant
UCSF Regional Pediatric MS Center
Dr. Jayne Ness
Center for Pediatric-Onset Demyelinating Disease at the Children's of Alabama
Contacts
Dr. Charlie Casper
University of Utah School of Medicine

General Design

Study design
Registry
Start - End Year
2011 -
General Information on Follow Up (profile, frequency)
Recruitment Target
  • Individuals
Number of Participants
2,500

Access

Availability of data and biosamples

Possible Access to Data
Possible Access to Biosamples
Other

Sector of research

Possible Access to Data Possible Access to Biosamples
Investigators from the public sector
Investigators from the private sector
Investigators from not-for-profit organization

Transfer

Possible Access to Data Possible Access to Biosamples
Can leave the study facility
Can leave the country

Cost

Possible Access to Data No Cost
Possible Access to Biosamples N/A

Cost reduction for co-analyses

Possible Access to Data
Possible Access to Biosamples

Marker Paper

Casper TC, Rose JW, Roalstad S, et al. The US Network of Pediatric Multiple Sclerosis Centers: Development, Progress, and Next Steps. J Child Neurol. 2015;30(10):1381-7.

PUBMED 4379142

Timeline

Population

PeMSDD population

Selection Criteria

Maximum age
21
Countries
  • United States of America
Health Status

Sources of Recruitment

Specific Population
  • Clinic patients
Supplementary Information

Sample Size

Number of Participants
2,500

Data Collection Events

# Name Data sources Data sources - Biosamples Start End
0 PeMSDD - Routine clinical visits
  • Questionnaires
  • Cognitive measures
  • Physical measures
2011 (May) Ongoing

Participating Studies

Acronym Name Study design Countries

Harmonization Initiatives Included

Acronym Name

Datasets

Name Data Collection Events Variables

Areas of Information Collected

Socio-demographic and economic characteristics
Death
Lifestyle and behaviours
Physical measures and assessments
Birth, pregnancy and reproductive health history
Laboratory measures
Perception of health, quality of life, development and functional limitations
Cognition, personality and psychological measures and assessments
Diseases
Life events, life plans, beliefs and values
Symptoms and signs
Preschool, school and work life
Medication and supplements
Social environment and relationships
Non-pharmacological interventions
Physical environment
Health and community care services utilization
Administrative information

Variables Content Summary

Areas of Information Collected
No Areas of Information Collected
No Scales Collected
Areas of Information Collected per per Population and Data Collection Event
No Areas of Information Collected
No Scales Collected

Networks

Acronym Name Harmonization Initiatives Individual Studies
Last Update: 2020-04-03T11:42:30.608